John Shaw

John Shaw is an Executive Director in Business Development at SK pharmteco, specializing in advanced therapy development and manufacturing since June 2023. With over 28 years of experience in biologics contract development, John held prominent roles including Head of Business Development at 3P Biopharmaceuticals and Vibalogics GmbH, where responsibilities included increasing global market presence and revenue. Prior positions included Business Development Manager at Biotec Services International, Business Manager at Cobra Biologics, and Account Manager at Cobra Biomanufacturing, focusing on customer relationship management and project leadership. John began the career as a Trainee Scientist at Therexsys Ltd and holds a BSc (Hons) in Applied Biology from Staffordshire University.